By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) 

11975 El Camino Real, Suite 101

San Diego  California  92130  U.S.A.
Phone: 858-792-6300 Fax: n/a


SEARCH JOBS

MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company's portfolio of drug candidates includes Pracinostat, a potential best-in-class, oral HDAC inhibitor currently in Phase II clinical studies for advanced hematologic diseases. The Company is also developing ME-344, a novel mitochondrial inhibitor that has shown evidence of clinical activity in refractory solid tumors, and ME-401 (formerly PWT143), a highly selective, oral PI3K delta inhibitor. For more information, please visit www.meipharma.com.

YEAR FOUNDED:

2000

LEADERSHIP:

CEO: Daniel Gold, PhD

CLINICAL TRIAL:

Please click here for clinical trial information.

JOB OPPORTUNITY:

Please click here for Mei Pharma job opportunities.


Key Statistics


Email: meiinformation@meipharma.com
Ownership: Subsidiary

Web Site: MEI Pharma
Employees:
Symbol: MEIP
 



Industry
Pharmaceutical






Company News
MEI Pharma (MEIP) Reports Fiscal Year 2016 Results 9/6/2016 10:06:14 AM
MEI Pharma (MSHL) To Present At Wedbush PacGrow Healthcare Conference 8/10/2016 10:50:01 AM
San Diego's MEI Pharma (MEIP) Bags Cancer Deal Worth $464 Million With Helsinn 8/8/2016 6:16:47 AM
MEI Pharma (MSHL)'s Pracinostat Called a Breakthrough By the FDA 8/1/2016 8:13:14 AM
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Present At Needham Healthcare Conference 4/5/2016 7:49:09 AM
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Present At BIO BIO CEO & Investor Conference 2/1/2016 9:04:29 AM
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Appoints Dr. Christine White As Chairman Of The Board 12/10/2015 7:53:27 AM
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces Positive Results From Phase II Study Of Pracinostat In Acute Myeloid Leukemia, Plans To Initiate Phase III Registration Study 12/7/2015 7:01:50 AM
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Host Annual Meeting Of Stockholders 11/23/2015 9:22:09 AM
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Present At Stifel Healthcare Conference 11/11/2015 10:18:09 AM
12345678910...
//-->